BioCardia, Inc.
BCDANasdaqCIK 925741HealthcareFiscal year ends Dec 31
Reports and events: 368 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1913:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032887 |
| 2026-10-0713:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032270 |
| 2026-10-0113:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031665 |
| 2026-09-2313:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031011 |
| 2026-09-2120:30 ET | 8-K | 8.01 Other events | 0001437749-26-030831 |
| 2026-09-1012:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030023 |
| 2026-08-2412:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-028778 |
| 2026-08-2120:34 ET | 8-K | 3.01 Delisting notice | 0001437749-26-028744 |
| 2026-08-1220:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027332 |
| 2026-08-1220:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027315 |
| 2026-06-1812:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-021041 |
| 2026-06-1212:00 ET | 8-K | 3.01 Delisting notice | 0001437749-26-020384 |
| 2026-06-0812:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-019789 |
| 2026-06-0512:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-019653 |
| 2026-05-2812:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-018670 |
| 2026-05-2112:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-017994 |
| 2026-05-1512:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017222 |
| 2026-05-1512:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017221 |
| 2026-05-0812:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015753 |
| 2026-04-2812:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-013535 |
| 2026-04-2012:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012764 |
| 2026-04-1520:30 ET | 8-K | 3.01 Delisting notice | 0001437749-26-012412 |
| 2026-04-0213:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-010967 |
| 2026-03-2420:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-009609 |
| 2026-03-2420:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-009587 |
| 2026-03-1710:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-008499 |
| 2026-03-0313:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-006481 |
| 2026-02-1014:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-003582 |
| 2026-02-0313:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-002723 |
| 2025-12-1613:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-037910 |
| 2025-12-0313:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-036711 |
| 2025-11-2413:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036076 |
| 2025-11-1221:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034442 |
| 2025-11-1221:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034437 |
| 2025-11-1013:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-033949 |
| 2025-11-0313:00 ET | DEF 14A | Proxy statementPeriod 2025-12-02 | 0001437749-25-032661 |
| 2025-10-3012:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-032289 |
| 2025-10-2920:24 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-06-30 | 0001437749-25-032197 |
| 2025-10-0720:15 ET | 8-K | 5.08 Item not in the standard list | 0001437749-25-030649 |
| 2025-10-0212:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-030217 |
| 2025-09-2412:00 ET | 8-K | 3.01 Delisting notice | 0001437749-25-029768 |
| 2025-09-2212:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-029547 |
| 2025-09-1916:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-029457 |
| 2025-09-1813:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029353 |
| 2025-09-1811:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029347 |
| 2025-09-1710:01 ET | S-1/A | Registration statement, amended | 0001437749-25-029214 |
| 2025-09-1613:04 ET | S-1 | Registration statement | 0001437749-25-029116 |
| 2025-08-1312:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-026356 |
| 2025-08-1113:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025826 |
| 2025-08-1113:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025827 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.